Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vita Coco Company (COCO) Shares Outstanding (Diluted Average) (2020 - 2026)

Vita Coco Company (COCO) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $60.5 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 0.83% year-over-year to $60.5 million; the TTM value through Mar 2026 reached $60.5 million, up 0.83%, while the annual FY2025 figure was $60.0 million, 1.15% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $60.5 million in Q1 2026 for Vita Coco Company, up from $60.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $60.5 million in Q1 2026 and bottomed at $55.7 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $58.5 million, with a median of $59.0 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Diluted Average) grew 5.56% in 2023 and then grew 0.07% in 2024.
  • Vita Coco Company's Shares Outstanding (Diluted Average) stood at $56.1 million in 2022, then rose by 4.67% to $58.7 million in 2023, then increased by 0.92% to $59.3 million in 2024, then grew by 1.15% to $60.0 million in 2025, then rose by 0.84% to $60.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $60.5 million, $60.0 million, and $59.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.